Docoh
Loading...

DYNT Dynatronics

Dynatronics is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The Company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The Company's products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Solaris™, Hausmann™, Physician's Choice®, and PROTEAM™, among others.

Company profile

Ticker
DYNT
Exchange
CEO
John A. Krier
Employees
Incorporated
Location
Fiscal year end
Former names
DYNATRONICS LASER CORP
SEC CIK
IRS number
870398434

DYNT stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

13 May 21
3 Aug 21
30 Jun 22
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Jun 20 Jun 19 Jun 18 Jun 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Dynatronics earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 4.65M 4.65M 4.65M 4.65M 4.65M 4.65M
Cash burn (monthly) (positive/no burn) (positive/no burn) 200.03K 328.86K 772.56K (positive/no burn)
Cash used (since last report) n/a n/a 826.78K 1.36M 3.19M n/a
Cash remaining n/a n/a 3.82M 3.29M 1.46M n/a
Runway (months of cash) n/a n/a 19.1 10.0 1.9 n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
9 Jul 21 John Anthony Krier Common Stock Grant Aquire A No No 1.14 12,500 14.25K 12,500
6 Jul 21 Baker Brian D. Common Stock Buy Aquire P No No 0 5,000 0 85,461
6 Jul 21 Baker Brian D. Common Stock Buy Aquire P No No 0 4,431 0 0
6 Jul 21 Essig Stuart Common Stock Buy Aquire P Yes No 0 5,000 0 100,601
6 Jul 21 Essig Stuart Common Stock Buy Aquire P Yes No 0 10,558 0 199,699
6 Jul 21 Essig Stuart Common Stock Buy Aquire P No No 0 52,604 0 1,560,666
6 Jul 21 Enright Erin S. Common Stock Buy Aquire P No No 0 5,000 0 100,601
6 Jul 21 Enright Erin S. Common Stock Buy Aquire P Yes No 0 10,558 0 199,699
6 Jul 21 Enright Erin S. Common Stock Buy Aquire P Yes No 0 52,604 0 1,560,666
6 Jul 21 Larkin Brian Common Stock Buy Aquire P No No 0 5,000 0 190,771

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

8.2% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 12 1 +1100.0%
Opened positions 12 1 +1100.0%
Closed positions 1 12 -91.7%
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 1.32M 1.32M -0.1%
Total shares 1.15M 1.63M -29.7%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Renaissance Technologies 700.07K $805K NEW
Vanguard 105.99K $122K NEW
Advisor 82.99K $96K NEW
Squarepoint Ops 82.05K $94K NEW
Geode Capital Management 61.16K $70K NEW
Two Sigma Advisers 27.7K $32K NEW
BLK Blackrock 22.09K $25K NEW
BAC Bank Of America 20K $23K NEW
Perritt Capital Management 17.84K $21K NEW
HRT Financial 16.61K $19K NEW
Largest transactions
Shares Bought/sold Change
Armistice Capital 0 -1.63M EXIT
Renaissance Technologies 700.07K +700.07K NEW
Vanguard 105.99K +105.99K NEW
Advisor 82.99K +82.99K NEW
Squarepoint Ops 82.05K +82.05K NEW
Geode Capital Management 61.16K +61.16K NEW
Two Sigma Advisers 27.7K +27.7K NEW
BLK Blackrock 22.09K +22.09K NEW
BAC Bank Of America 20K +20K NEW
Perritt Capital Management 17.84K +17.84K NEW

Financial report summary

?
Management Discussion
  • Net sales decreased $2,246,000, or 16.4%, to $11,460,000 for the quarter ended March 31, 2021, compared to net sales of $13,706,000 for the quarter ended March 31, 2020. Net sales decreased $9,732,000, or 21.5%, to $35,561,000 for the nine months ended March 31, 2021, compared to net sales of $45,293,000 for the nine months ended March 31, 2020. The year-over-year decrease is primarily due to the continued impact of COVID-19, including reduced demand for our products, reduced capacity and operating hours, supply chain disruptions, and extended handling times. Extreme weather conditions also caused production disruptions during the quarter ended March 31, 2021.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: American, announced, calendar, complexity, consummated, Consummation, cost, counted, deliver, EBITDA, expanded, Extreme, handling, higher, Leaf, legislation, Maple, maximum, million, Mountainview, mutual, objective, occupied, Ooltewah, outlook, party, portfolio, Realco, refundable, Rescue, restructuring, retention, Road, streamline, support, termination, usage, USD, weather
Removed: apply, interim